CAS 1976050-09-5

Fórmula: C16H10F3N5

InChI: InChI=1S/C16H10F3N5/c17-16(18,19)13-11-4-3-10(8-9(11)5-7-20-13)22-15-12-2-1-6-21-14(12)23-24-15/h1-8H,(H2,21,22,23,24)

Chave InChI: RUEXKBWCUUFJMY-UHFFFAOYSA-N

SMILES: C1=CC2=C(NN=C2N=C1)NC3=CC4=C(C=C3)C(=NC=C4)C(F)(F)F

Valiglurax

CAS: 1976050-09-5

Valiglurax

Fórmula: C₁₆H₁₀F₃N₅

Pureza: ≥95%

Peso molecular: 329.28

Ref: 54-BUP14249

Valiglurax

CAS: 1976050-09-5

Fórmula: C₁₆H₁₀F₃N₅

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 329.2793

Ref: IN-DA01XENL

Valiglurax

CAS: 1976050-09-5

Potent and selective positive allosteric modulator (PAM) of metabotropic glutamate receptor mGlu4. Valiglurax is orally bioavailable and CNS-penetrant mGlu4 PAM in preclinical development for the Parkinson’s disease therapy and alleviation of the motor symptoms.

Fórmula: C₁₆H₁₀F₃N₅

Pureza: Min. 95%

Cor e Forma: Solid

Peso molecular: 329.28 g/mol

Ref: 3D-BV168436

Valiglurax

CAS: 1976050-09-5

Valiglurax (VU2957), potent mGlu4 PAM, crosses blood-brain barrier, orally available; promising for Parkinson's treatment.

Fórmula: C₁₆H₁₀F₃N₅

Pureza: 98.29%

Cor e Forma: Solid

Peso molecular: 329.2793

Ref: TM-T35028